English 
French 
Enhancing Lives Since 2014
Since our establishment in 2014, Exzell Pharma has been committed to enhancing the health and well-being of Canadians through a comprehensive range of high-quality pharmaceutical and natural health products.
As we have expanded our portfolio to address the evolving needs of both human and animal health, our focus on innovation and care has remained unwavering. With the strategic partnership of Biolab Farmacêutica Group since 2022, we are well-positioned for continued growth and are excited to bring even more effective healthcare solutions to Canadians.
to Continuous Growth
As we look to the future, Exzell Pharma remains dedicated to enhancing our portfolio with innovative, high-quality products that meet the evolving health needs of Canadians. With exciting new developments on the horizon, we aim to continue delivering effective and comprehensive health solutions for individuals, families, and pets nationwide. Our mission remains clear: to provide Canadians with safe, affordable, and effective health solutions that improve their quality of life.
August
We expanded our digestive care portfolio by re-introducing Swiss Natural® Activated Charcoal, formulated to relieve gas and bloating. This addition strengthens our commitment to offering natural, effective health solutions to Canadians needing digestive support.
July
Swiss Natural® Menolibrium® was introduced in the Canadian market as a natural, hormone-free solution for menopause symptoms. Powered by the clinically proven ingredient EstroG-100®, it offers Canadian women a safe and effective alternative, underscoring our dedication to their health and wellness.
June
We introduced OGRAX–3, an essential fatty acid supplement for dogs and cats sourced from marine fish. This launch highlights our commitment to providing premium pet nutrition and reflects our strong presence in the expanding Canadian pet care market.
February
Butterly Award Recognitions, Ozonol® Ointment and Swiss Natural® Super Papaya Enzyme were honoured with the 2024 Butterly Reviewers’ Choice Award, a prestigious recognition celebrating excellence in consumer healthcare. Winning the Reviewers’ Choice Award reinforces Exzell Pharma’s dedication to delivering high-quality, trusted healthcare solutions that improve the lives of Canadians every day.
In 2023, we ventured into Animal Health, launching Exzell Animal Health to meet the growing demand for quality pet care. This exciting new chapter reflects our commitment to health and wellness for both people and their beloved pets, offering solutions that support their well-being in an evolving market.
A pivotal moment in our journey occurred in 2022 when Exzell Pharma became a subsidiary of Biolab Farmacêutica. This partnership opened new doors, enabling us to expand our product lines. Strategically positioned within the global marketplace, we are now in an even stronger position to bring innovative, effective healthcare solutions to Canadians.
The addition of Salinex®, one of Canada’s pioneering nasal spray brands, marked a major milestone in Exzell Pharma’s portfolio expansion. This product strengthened our offerings in respiratory care. In the same year, we introduced PediaVit™ as part of our portfolio, a line of vitamin and iron supplements for young children, ensuring that Canadian families had the necessary nutrients for their children’s healthy development from infancy through toddlerhood.
In 2018, Exzell Pharma introduced EsopH®, an innovative therapy for managing GERD (Gastroesophageal Reflux Disease) symptoms like heartburn and acid reflux. This groundbreaking oral therapy became an effective solution for Canadians seeking relief, offering protection to the esophagus and helping manage symptoms whether used alone or alongside prescription Proton Pump Inhibitors (PPIs).
In December 2017, Exzell Pharma acquired Swiss Natural®, a well-established brand known for its high-quality vitamins and supplements. This addition expanded our portfolio in the health and wellness category, reinforcing our commitment to providing Canadians with trusted, natural health solutions.
In December 2016, Exzell Pharma acquired Myoflex® and Ozonol®, two trusted Canadian healthcare brands, strengthening our commitment to providing effective pain relief and wound care solutions. This strategic expansion reinforced our position in the market and allowed us to continue delivering high-quality products to Canadian consumers.
Exzell Pharma was founded with a clear mission: to provide Canadians with trusted, high-quality health solutions. Seeking legacy brands laid the foundation for our ongoing dedication to offering accessible, effective products for everyday health needs in the future years.